Emergent BioSolutions is a biopharmaceutical company that makes and supplies medical countermeasures like vaccines and treatments. Its filings show it lobbies Congress for funding and reauthorization of pandemic preparedness laws and related programs, including the Strategic National Stockpile and other biodefense and homeland security efforts. It recently spent about $200,000 and hired the CGCN Group to advocate on these issues.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JA'RON SMITH
The latest disclosures for this client.
CGCN GROUP, LLC
Q4CGCN GROUP, LLC
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CGCN GROUP, LLC
JILL HAMAKER
CGCN GROUP, LLC
mrs MARTHA BEATRICE MILLER
CGCN GROUP, LLC
SCOTT RIPLINGER
CGCN GROUP, LLC
CGCN GROUP, LLC
Q2CGCN GROUP, LLC
Q1